md-medicaldata

Authors

 

Raquel Martínez-Rodríguez¹, Milan Knežević¹, Gordana Anđelić², Ana Cinta Vicente-Guerra³, Aldo Suárez-Soto¹, José María Castellano¹, Mario Vicente-Barrero¹, Milena Knežević<sup>1

1</sup>Universidad Las Palmas Gran Canaria, Máxillofacial Surgeon Spain
²Military Medical Academy, Institute for Medical Research, Belgrade, Serbia
³Universidad Federada San Judas Tadeo, Costarica

 

UDK: 616.447-006.03(460.41)"2010/2015"

The paper was received 29.01.2018. Accepted: 07.02.2018

Rad primljen 29.01.2018. Rad prihvaćen: 07.02.2018.

 

Corresponding author/ Autor za korespodenciju:

Gordana Anđelić
Institute for Medical Research,
Military Medical Academy
Belgrade, Serbia
e-mail: gordana.andjelic13@gmail.com
tel/fax. +381 11 2662 722
cellular. + 381 64 1924274

 

 

Abstract

 

Introduction: Benign tumors of the parotid gland are an infrequent and heterogeneous group due to their histological differences. Their etiology has been unknown until now, although they are more frequent in some racial groups and in people exposed to tobacco and radiation. They are common from the fourth decade of life, characterized by being a mass with slow, asymptomatic growth and they rarely recur. Most of them are diagnosed after physical examination, and an FNAB (fine needle aspiration biopsy). Treatment is surgical.
Material and methods: A retrospective and descriptive study of benign tumors was conducted in the population of the south area of the island Gran Canaria and Fuerteventura Island. The study was done on parotid gland tumors detected in 123 patients who visited the Clinic for Maxillofacial Surgery of the University Hospital in Las Palmas during the years 2010 - 2015.
The patients were classified according to the histological type of tumor, age, gender, mean hospital stay and clinical characteristics of the tumor. Results: Focused on the pleomorphic adenoma, the results obtained in our study did not show significant differences regarding clinical characteristics in different studies. This tumor was diagnosed in 54% of the cases of total tumors diagnosed, and it was more frequent in women. However, in the comparison, the Warthin tumor showed a high incidence in our population, with 42% of total cases, 9.6% from which developed bilaterally.
Conclusions: The tumors have male predominance, with the exception of the pleomorphic adenoma. Our population agrees with that of other authors regarding the incidence of pleomorphic adenoma, however, the number of Warthin tumors is much higher.

 

 

Key words:

pleomorphic adenoma, parotid gland tumors, Warthin tumor, frequency

 

 

Sažetak

 

Uvod: Dobroćudni tumori parotidne žlezde su retka i heterogena grupa tumora zbog svojih histoloških osobina. Njihova etiologija do sada nije bila poznata, iako su učestaliji kod pripadnika određenih rasa i ljudi izloženih duvanskom dimu i radijaciji. Učestali su od četvrte decenije života, Karakteriše ih masa sporog, asimptomatskog rasta, i retko se recidiviraju. Najveći broj se dijagnostikuje nakon kliničkog pregleda i iglene aspiracione biopsije. Leči se hirurškim putem. Materijal i metode: Retospektivna i opisna studija benignih tumora je bila izvršena na južnom delu populacije ljudi sa Velikog Kanarskog ostrva i Fuertenventura ostrva. Studija je odrađena na tumorima parotidne žlezde koji su detektovani kod 123 pacijenta koji su pregledani na Klinici za maksilofacijalnu hirurgiju u Univeritetskoj bolnici Las Palmasa u periodu od 2010 do 2015. Results: Imajući u vidu pleomorfni adenom, rezultati nisu pokazali značajnu razliku između karakteristika u različitim kliničkim stadijumima. Ovaj tumor je dijagnostikovan kod 54% svih pacijenata sa tumorima, i češći je kod žena. Ali u proeđenju, Warthin tumor je pokazao veću učestalost u našoj populaciji, sa 42% učestolasti, od kojih se 9.6% razvilo bilateralno. Zaključak: Tumori su učestaliji u muškoj populaciji, sa izuzetkom pleomorfnih adenoma. Naši rezultati su u saglasnosti sa studijama drugih autora o učestalosti pleomorfnih adenoma, sa izuzetkom Warthin tumora koji su mnogo češći.

 

 

Ključne reči:

pleomorfni adenomi, tumori parotidne žlezde, Warthin tumori, učestalost

 

 

Reference / Literatura

 

1. National Cancer Institute(2016). Cáncer de glándulas salivales.Accedido 8 de mayo de 2017 en https://www.cancer.gov/espanol/tipos/cabeza-cuello/pro/tratamiento-glandulas-salivales-pdq#section/_1.
2. Martorel, V.; Salmerón, J.I.,(2016)Tumores de la glándula parótida. Rey. Sánchez,G(Eds) Protocolos de la SociedadEspañola de Cirugía Oral y Maxilofacial, 2016(cap50) Madrid
3. Acta Otorrinolaringológica Española (2017). Salivary Duct Carcinoma: Diagnostic Clues, Histology and Treatment. Accedido 6 de marzo de 2017 en http://www.elsevier.es/en-revista-acta-otorrinolaringologica-espanola-402-articulo-salivary-duct-carcinoma-diagnostic-clues-S2173573513000380
4. Cisternas M.J., Corrochano E.O., Saa Álvarez M.R. (2015) Introducción a la patología tumoral de las glándulas salivares. Cáceres: SEORPCF
5. Amano,O.; Mizobe,K.; Bando,Y.; Sakiyama,K. ;(2012)Anatomy and histology of rodent and human major salivary glands.(Cap45: pag 241-250) Japón
6. Pérez,G.(2016).Síntomas de cáncer de glándulas salivales (parótidas): primeros, iniciales. Accedido 13 de marzo de 2017.en http://cancersintomas.com/cancer-de-glandulas-salivales
7. Moreno, C.; Pons García M. A.; González García, R.; Ruiz Laza, L,; Monje Gil,F. (2009): Lesión linfoepitelial quística benigna de glándula parótida en paciente con infección por VIH.Revista Española de Cirugía Oral y Maxilofacial31, no 3 203-6.
8. Heinsen, R.; Wally,J.; Paolo,C.;  Jazmín Guevara L.; Gómez Rodríguez,J.L.; Jaén Díaz, J.I.; ,Cordero García,B.;( 2014). Tumor de parótida bilateral y múltiple. Revista Clínica de Medicina de Familia 7, no 2 148-51.
9. Ellis,G.L.; Auclair, P.L.(1996),Atlas of Tumor Patología, 3,Tumors of i.e.Salivary Glands.  Washington, DC:Forges. 
10. Cooper, J. S.;Fu,K,; Marks, J.; Silverman,S.; (1995): Late Effects of Radiation Therapy in the Head and Neck Region.International Journal of Radiation Oncology, Biology, Physics 31, no 51141-64
11. Fernandez, G.C.; Pandit, A.A.;(2002)El diagnóstico de tumores de glándulas salivales por FNAC. Bombay Hosp J; 4 ,201-6.
12. Romero Fazzini. (2000). Tumores de glándulas salivales, Accedido 15 de marzo de 2017 en http://www.sld.cu/galerias/pdf/sitios/cirugiamaxilo/tumoresglandulassalivales.pdf.
13. Masanja,M.I.; Kalyanama, B.M.; Simon, E.S.; (2003)Tumores de glándulas salivales en Tanzania. Este Afr Med J; 80: 429-34.
14. Donohue Cornejo,A.;(2014) .Tumor de Warthin: Una experiencia del Hospital «General Calixto García». La Habana, Cuba. ROMvol.18, n.3, pp.164-169
15. Rom,J.; Morphol,E.; (2016). Diagnostic and Therapeutic Aspecs in Malignant Sinonasal Lymphoma, Accedido 30 de abril de 2017. En https://www.ncbi.nlm.nih.gov/pubmed/27151713
16. Hernández-Da, S. E.; Cornejo-Ballesteros, R.H.;(2008). Enfermedad de Mikulicz Como Parte Del Síndromede Sjögren. RMOl; 82(4):256-259.
17. Cantisani,V.Emanuele,D.; Virgilio,A.; Paul,S.; Grazhdani,S,H.: Greco,A.; Vincentiis,M.; (2017)Prospective Evaluation of Quasistatic Ultrasound Elastography (USE) Compared with Baseline US for Parotid Gland Lesions: Preliminary Results of Elasticity Contrast Index (ECI) Evaluation.Medical Ultrasonography 19, no: 32-38.
18. Harriet C.(2007).Imaging of salivary gland tumours. Cancer Imaging 7, n.o 1: 52-62.
19. Scanlon, E. F.; Sener. S. F (1981). Head and Neck Neoplasia Following Irradiation for Benign Conditions. Head & Neck Surgery 4, no 2: 139-45.
20. Isa,M.; Göze,F.; Ezirganl,S.; Polat,S.;  Muderris,S.;  Elagoz.S.; (2010).Neoplasms of the Salivary Glands in a Turkish Adult Population.Medicina Oral, Patología Oral Y Cirugía Bucal 15, no 6: e880-885.
21. Fonseca, F. P.; Vasconcelos Carvalho,M.;  Paes de Almeida,O.;Carrinho Ayroza,A.L.; Hirata Takizawa,M.C.; Galvão Bueno,A.;Vargas.P.A.(2012): Clinicopathologic Analysis of 493 Cases of Salivary Gland Tumors in a Southern Brazilian Population. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 114, no 2 230-39.
22. Ahmed.L.; Akinyele,O.; Adisa,O.;Kolude,B.; Bukola,F.; Mofoluwaso A. (2013). A review of 413 salivary gland tumours in the head and neck region.Journal of Clinical and Experimental Dentistry 5, no 5 218-22.
23. Zacharie,S.; Fokouo,J.V.; Onomo Mebada,A.; Djomou,F.; Djolo,A.;Essame Oyono,J.L. (2016), Epidemiological and histopathological patterns of salivary gland tumors in Cameroon. The Pan African Medical Journal 23.
24. Lee, Wei-Han, Te-Ming Tseng,Hsin-Te Hsu, Fei-Peng Lee, Shih-Han Hung, Po-Yueh Chen (2014).Salivary gland tumors: A 20-year review of clinical diagnostic accuracy at a single center.Oncology Letters 7, no 2 583-87.
25. Mejía-Velázquez, C, P.;, Marco, A.; Durán-Padilla, E.; Gómez-Apo, D.; Gaitán-Cepeda. L. (2012): Tumors of the salivary gland in Mexicans. A retrospective study of 360 cases.Medicina Oral, Patología Oral y Cirugía Bucal 17, no 2e183-89
26. Muñoz Palza, C.;Cordero Jiménez, A.;Tenor Serrano,R.; García Mata,R.; Contreras Molina, P.; García Muñoz. I. (2009). Correlación citohistológica en tumores de la glándula parótida. Acta Otorrinolaringológica Española, s. f., 184-88
    
    

PDF Martínez-Rodríguez R. et al • MD-Medical Data 2018;10(1): 045-049